{
  "ticker": "LLY",
  "target_date": "2025-06-18",
  "actual_date": "2025-06-18",
  "collected_at": "2025-12-08T11:54:32.468068",
  "price": {
    "open": 787.06,
    "high": 787.74,
    "low": 776.59,
    "close": 782.160888671875,
    "volume": 2442900,
    "change_1d_pct": -0.78,
    "change_7d_pct": 1.46,
    "change_30d_pct": 1.49
  },
  "technicals": {
    "rsi_14": 73.76,
    "sma_20": 760.35,
    "sma_50": 773.29,
    "macd": 9.668,
    "macd_signal": 4.307,
    "macd_histogram": 5.361,
    "bb_upper": 832.96,
    "bb_lower": 687.74,
    "price_vs_sma20_pct": 2.87,
    "price_vs_sma50_pct": 1.15,
    "volume_ratio": 0.75
  },
  "fundamentals": {
    "market_cap": 892100018176,
    "pe_ratio": 48.757473,
    "forward_pe": 43.916153,
    "price_to_book": 37.46762,
    "price_to_sales": 15.0135145,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.51,
    "pct_from_52w_low": 59.53
  },
  "macro": {
    "spy": {
      "price": 594.03,
      "change_1d_pct": -0.02,
      "change_7d_pct": -0.94
    },
    "vix": {
      "level": 20.14,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.4
    },
    "dollar_index": {
      "level": 98.91
    },
    "gold": {
      "price": 3389.8
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug",
      "source": "Finnhub",
      "datetime": 1750273335,
      "summary": "Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the...",
      "url": "https://finnhub.io/api/news?id=50eebf950cba06c42fdea6547b8c49248a5feb4711054fc929e0a50a2029df75"
    },
    {
      "headline": "Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results",
      "source": "Yahoo",
      "datetime": 1750261233,
      "summary": "Shares of Scholar Rock Holdings jumped Wednesday after the biopharmaceutical firm reported positive results from a weight-loss drug trial.",
      "url": "https://finnhub.io/api/news?id=e9f17bc16490d5af00cf51972e9d70aefbffbe3cf8adc06729ae775cb3195e61"
    },
    {
      "headline": "Indexes briefly add to gains after Fed statement, trade volatile",
      "source": "Finnhub",
      "datetime": 1750257131,
      "summary": "* Concerns about Middle East persist * Iran leader rejects Trump's demand for surrender * Indexes up: Dow 0.3%, S&P 500 0.3%, Nasdaq 0.4% ...",
      "url": "https://finnhub.io/api/news?id=55a78f64468a254205014d1823090c826df091f7ff847ecd9aae2027e8cc5c32"
    },
    {
      "headline": "GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?",
      "source": "Yahoo",
      "datetime": 1750256520,
      "summary": "GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine headwinds.",
      "url": "https://finnhub.io/api/news?id=547e450da5dab1f49048cfe0f806d54a87f7c3d641b4306da95706f540275b12"
    },
    {
      "headline": "How a Solar Factory in the Heartland Sees the \u2018Big Beautiful Bill\u2019",
      "source": "MarketWatch",
      "datetime": 1750255680,
      "summary": "How a Solar Factory in the Heartland Sees the \u2018Big Beautiful Bill\u2019",
      "url": "https://finnhub.io/api/news?id=02585e0565e97ce8d93d0f4a327476c473e7a6a7da29e6f41e39cbe4b43bdc59"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199300.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/xslF345X05/wk-form4_1750199300.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199159.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/xslF345X05/wk-form4_1750199159.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198988.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/xslF345X05/wk-form4_1750198988.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198711.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/xslF345X05/wk-form4_1750198711.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198504.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/xslF345X05/wk-form4_1750198504.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}